PhuturdexDrug Pipeline Intelligence

Phuturdex › Diseases › Endometriosis

Drugs in development · updated 30 October 2026

Endometriosis: drugs in development

As of 30 October 2026 there are 18 active clinical trials (recruiting or ongoing, phases I–III) on 16 drugs for endometriosis. 6 are experimental, that is not yet approved in the United States.

18Active trials
6Experimental drugs
3Experimental, in phase III

Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.

Sign in free →

Experimental drugs

Not yet approved by the US FDA for any indication.

DrugMost advanced phaseActive trialsReference trial
HMI-115III1NCT07318688
Indole-3-carbinolIII1NCT07164183
KLH-2109III1NCT07015268
[18F]FAPI-74I–II1NCT07705074
VipoglanstatII1NCT07260669
Salsalate PillEarly I1NCT05069740

Sorted by most advanced phase and number of active trials.

Approved drugs in new trials

Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.

DrugMost advanced phaseActive trialsReference trial
RelugolixOrgovyx®III3NCT06439524
ElagolixOrilissa®III2NCT04333576
Leuprolide AcetateLeuprorelin, LupronIII2NCT07015268
DienogestIII1NCT07164183
EsketamineSpravatoIII1NCT06161805
TriptorelinTriptorelin Embonate, Triprorelin AcetateIII1NCT06525155
CannabidiolEpidiolex, Epidyolex®II1NCT06477406
DesloratadineDesloratodine, Clarinex®II1NCT07821320
MetforminRiomet Er®, Glumetza®II1NCT06611501
RimegepantBHV3000, Nurtec Odt®II1NCT07795125

Sorted by most advanced phase and number of active trials.

All 16 drugs, with the details

In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.

Open in Phuturdex →

Broader categories

Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D004715 “Endometriosis”.

ItalianoFrançaisDeutsch